chrisvoncsefalvay/vaers-outcomes huggingface dataset:
high fever, severe pain, dizziness, vomitting, internal bleeding, stroke, sepsis
Waves of body shaking chills for a day and a half. Nausea, heavy legs, headache, muscle aches.
pt recv vax 1JUN98 & pt reports s/s 4JUN98 AM of sore throat, tongue, face swollen, urticaria;DPH, Decadron pt responded to tx;
APPROXIMATELY 10 MINUTES AFTER VACCINATION PATIENT REPORTED DIZZINESS, POSSIBLE DIFFICULTY BREATHING. 0.3MG EPINEPHRINE WAS ADMINISTERED, PATIENT WAS MONITORED, AND PATIENT WENT TO THE HOSPITAL WITH E.M.T.S. BLOOD PRESSURE WAS NORMAL, AND PATIENT REMAINDED CONSCIOUS. SHE COULD SPEAK.
Dizziness, trouble breathing, balance cant walk, chest pains, very bad headache, vomiting, rapid heart beat, felt my throat was closing. Face felt flushing.
Information has been received from a licensed practical nurse concerning a 6 year old male patient with no allergies and no past medical history who on 24-Oct-2003 was vaccinated in the right arm with a first dose of varicella virus vaccine live (Lot #644723/0073N). There was no concomitant medication. On 27-Oct-2003, the school nurse called the doctor's office to report that the patient had broken out in a rash all over his body with a few spots and a lesion or two. The reporter stated that they believed the rash was caused by flea bites. An onset date of 27-Oct-2003 was noted. The patient presented to the office the next day and the physician confirmed it was flea bites. No treatment was given. The reporter confirmed this was not an adverse reaction to the vaccine. A product quality complaint was not involved. Additional information is not expected.
Began with feeling exhausted and sleepy within a few hours.  Progressed to aching throughout body, painful L arm and stiff neck.   By 9pm unable to elevate L arm, unable to turn head and blazing headache.  Symptoms continued for 24 hours.  Began to decrease and bu the 36th hour was nearly normal.  It has now been 4 days since vaccination and I?ve resumed normal lifestyle......but have residual ?fatigue? in late afternoon.
Kinrix given to a 15 month old patient; Kinrix administered instead of Dtap (infanrix); This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old male patient who received DTPa-IPV (Kinrix) (batch number E2L54, expiry date 3rd March 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: It was reported that the 15 months old patient received Kinrix instead of Dtap (infanrix), which led to inappropriate age at vaccine administration and wrong vaccine administered. The vaccine history series was for 15 month old was 4th dose for dtap and 4th dose for ipv. The reporter consented to follow up. This case has been linked with case US2022039286 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022039286:same reporter
Fevers every few weeks (102-105), photophobia, memory loss, loss of consciousness, extreme behavior change, tachycardia. Diagnosis: autoimmune encephalitis. Treatment: Steroids, IVIG (Feb 2017)  Rituximab (May and July 2017).
I had the normal injection site pain and pain in arm a day or two after the shot. But now a week later I have a large red rash that is warm to the touch and very itchy. It doesn't hurt.
Patient was vaccinated 1/28/21 and 2/25/21 with Moderna.  He became COVID  positive 1/8/23 and expired 1/19/23.
Six weeks after taking the 2nd dose I had to go to the emergency room. I was experience itching all over my body. I had urcicaria. A week after I woke up with chest pain. I had an emergency cardio Cath and had 2 stints put in. 2 weeks after that I had to get 2 more stints and a angioplasty.  Since then my blood pressure is out of control, my kidney function is declining, and I've had an allergic reaction that is currently being monitored.
Initial misuse report received from a healthcare professional on 13 May 2013. A 23-month-old child was administered the fifth dose of DAPTACEL in the series because the fourth dose administered 11 months after the third dose which was not initially charted. No adverse event was reported. List of documents held by sender: none.
I received no treatment because I just figured out early last year that this was a problem.  It is getting worse so I plan to see a doctor.
pt recvd vax 7DEC94; 930AM 8DEC94-nap, asleep for about 10 mins then awoke crying (unconsolable for 10-15 mins, never opened eyes; rt eye tearing; would not open eyes;
This spontaneous report was received from a pharmacist regarding an unspecified patients of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date since 15-FEB-2016, the patients were vaccinated with improperly stored ZOSTAVAX lot # L028286, expiration date- 28-OCT-2016 and lot # L035505, expiration date-16-DEC-2016. No adverse event was reported. No concomitant medication was reported. The outcome of the event was unknown. Temperature and Time frame was 20F for 11 hours and 6F for 15 hours and there was no previous temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested.
Facial itiching with hypersensitive skin started a 2-3 days after injection. Swelling of face and eyes and blotchy facial skin 13 days after injection. Seen by ED physician for steroids and benadryl. Slight decrease in swelling 24-36 hrs post start of steroid regimen.
COLD SWEATS; COUGHING; DIARRHEA; TIRED AND SLEEP; NAUSEA; This spontaneous report received from a consumer concerned a 44 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1808982, expiry: UNKNOWN) dose was not reported, administered on 14-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-MAY-2021, the subject experienced cold sweats. On 14-MAY-2021, the subject experienced coughing. On 14-MAY-2021, the subject experienced diarrhea. On 14-MAY-2021, the subject experienced tired and sleep. On 14-MAY-2021, the subject experienced nausea. The action taken with covid-19 vaccine  was not applicable. The outcome of the cold sweats, tired and sleep, diarrhea, coughing and nausea was not reported. This report was non-serious.
Pfizer vaccination lot FL2757 was potentially received short-dated and recently expired. No adverse effects reported by patient
adult patient received a pediatric dose of Engerix-B.; adult patient received a pediatric dose of Engerix-B.; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 21-year-old male patient who received HBV (Engerix B) (batch number LP724, expiry date 18th May 2023) for prophylaxis.   On 6th April 2022, the patient received the 1st dose of Engerix B. On 6th April 2022, unknown after receiving Engerix B, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK Receipt Date: 08-Jun-2022 Reporter's Comments: Medical Assistant reported that the adult patient received a pediatric dose of Engerix-B. The reporter consented to follow up. Additional Supportive Information: The adult patient received pediatric dose of Engerix B, which led to underdose and adult use of a child product.
Lg Rounder RT Arm, Cough, fever last night and whezzing Asthmas and shots reaction on RT arm. fever last night eureore us vanicella, Dtap 4/11/07 R arm. Large rounded RT amrm vaccination reaction local rash - erthema (normal local ta
This spontaneous report was received from a registered nurse and refers to a 13 month old female patient. The patient's concurrent conditions and medical history were not reported. Stock of vaccine was received on 11-AUG-2016. On 03-NOV-2016, the patient was vaccinated with an improperly stored dose of PROQUAD lot # M018636 with expiration date of 12-JUL-2017 (dose, route and frequency were not reported) reconstituted with properly stored sterile diluent (DILUENT MRK) for prophylaxis. No adverse effects were reported. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 37 days. It was reported that there was no need to repeat vaccine. No previous temperature excursion. The call was not because of a "data logger". There was no Product Quality Complaint (PQC) involved in this case. No further information was provided. This is one of the several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA013888:
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Jan2023 at 13:30 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 35 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "pcos" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "adhd" (unspecified if ongoing); "depression" (unspecified if ongoing); "Known allergies: Mangos, kiwi, aguacate" (unspecified if ongoing). Concomitant medication(s) included: DULOXETINE, start date: 12Dec2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 including Paxlovid from 03Mar2023. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Reaction started on 1/5/20. Site is red, hard, itchy, hot to touch, and raised approximately 2-3 cm. Remains afebrile. Seen by Provider via Telemedicine.
sore arm excruciating; swelling arm; Hot to touch; Redness; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (sore arm excruciating), PERIPHERAL SWELLING (swelling arm), FEELING HOT (Hot to touch) and ERYTHEMA (Redness) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 048A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm excruciating), PERIPHERAL SWELLING (swelling arm), FEELING HOT (Hot to touch) and ERYTHEMA (Redness). On 17-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm excruciating), PERIPHERAL SWELLING (swelling arm), FEELING HOT (Hot to touch) and ERYTHEMA (Redness) outcome was unknown.            Concomitant product use was not provided by the reporter.   No treatment information was provided  Action taken with mRNA-1273 in response to the event was not applicable.
Large area of redness, swelling, itching and warm to touch around injection site. Approx. 5 inches around site. I started taking benadryl today.
Fever; Chills; Lethargy; Body aches; Congestion; Coughing; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 19Apr2021 at 12:30 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS), rheumatoid arthritis and allergy to metal except for surgical steel. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive concomitant medications. The patient previously received tramadol hydrochloride (ULTRAM) for unspecified indication from unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 29Mar2021 at 12:30 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. On 20Apr2021 at 07:00, the patient experienced fever, chills, lethargy, body aches, congestion and coughing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, lethargy, body aches, congestion and coughing was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Information has been received from a consumer concerning a patient who was vaccinated with varicella virus vaccine live. Subsequently the patient developed shingles. Additional information has been requested.
About 28 minutes after receiving I started getting hot, I could feel my heart racing in my chest, my breathing quickened, rapid response was called taken into another room by then my fingers had cramped up to where I couldn't work then arms and legs felt like pins & needles. Sent by ambulance to nearest ER where I was given benadryl and Solu-Medrol by IV, given another dose before being discharged with a prescription for Methprednisolone a few hours later.
I tested positive for Covid 19 on October 16, 2022 I experienced  fever, headache, sore throat, bad cough, muscle and joint pain I started losing taste and smell on October 14, 2022 also had a runny nose. I was prescribed Paxlovid for my symptoms No
Noticed big skin patch on head.  Followed by excessive hair shedding.  Got kenalog steroid injection in head, applying clobetasol and rogaine. Tried PRP and exosomes.
I could feel flutters that I was having; he tells me that my heart has got out of rhythm when I took that shot; my blood pressure started coming down but my heart rate stayed not like that but somewhere 140-150 till 3rd morning; blood pressure and it was 204/108/The blood pressure is high and it still goes up to the 60s and 180 but I have no symptoms of whatsoever that anything is wrong; He said that was causing an allergic reaction and got my heart out of rhythm; I woke up and I was just really hot; My head was wringing wet; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262, expiration date: May2021), via an unspecified route of administration on 22Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Consumer stated that the patient just wanted to let them know because they had told in patient's thread on the paper if you have any kind of allergic reaction to let them know. The patient went over to get the shot last Friday (22Jan2021) and about the time the patient got somewhere in the eastern area the patient could feel flutters that the patient was having so the patient came back home, the patient took his/her blood pressure and it was 204/108 and the patient heart rate was 140 something. So, the patient called the doctor and he told the patient to take a Benadryl, lay down for 2 hours. It did not go away.  The patient needed to go to the ER. Well, the patient's blood pressure started coming down but the patient heart rate stayed not like that but somewhere 140-150 till 3rd morning (in Jan2021). The blood pressure was high and it still went up to the 60s and 180 but the patient had no symptoms of whatsoever that anything was wrong. Other than there in the night, that Friday night (22Jan2021), the patient woke up and the patient was just really hot. The patient's head was wringing wet. But he/she got no fever. The patient got up and she/he stood up 30 minutes and the patient took his/her blood pressure and the patient thought it was maybe 180 and the pulse was still high and now when the patient took it, it went like start out at 80 and goes around like 66. Consumer stated that the patient did not go because she/he had got an appointment with a doctor Thursday (Jan2021) and the patient did not go. The patient did not feel bad but he told the patient that his/her heart had got out of rhythm when the patient took that shot. He said that was causing an allergic reaction and got the patient heart out of rhythm. So, the patient was just concerned about the 2nd shot. The outcome of the events was unknown.
Per patient verbal report "dizzy, heart racing and pounding".  Vital signs at initial report were: HR 76, RR 24, BP 112/68, Temp 97.6.  Appeared pale and sweaty.  Taken to Emergency Department per recommendation of Dr. for evaluation.
throwing up; vomiting started today; no appetite; pain in the legs; feel like muscle pain but not whole muscle; feeling nasty; nauseated the last couple of days; shaking real bad; heart rate went up; blood pressure went up; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), PAIN IN EXTREMITY (pain in the legs), MYALGIA (feel like muscle pain but not whole muscle), FEELING ABNORMAL (feeling nasty) and NAUSEA (nauseated the last couple of days) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Pyrexia, BUPRENORPHINE HYDROCHLORIDE (SUBUTEX) for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced TREMOR (shaking real bad), HEART RATE INCREASED (heart rate went up) and BLOOD PRESSURE INCREASED (blood pressure went up). On 15-Apr-2021, the patient experienced DECREASED APPETITE (no appetite), PAIN IN EXTREMITY (pain in the legs), MYALGIA (feel like muscle pain but not whole muscle), FEELING ABNORMAL (feeling nasty) and NAUSEA (nauseated the last couple of days). On 20-Apr-2021, the patient experienced VOMITING (throwing up; vomiting started today). At the time of the report, DECREASED APPETITE (no appetite), PAIN IN EXTREMITY (pain in the legs), MYALGIA (feel like muscle pain but not whole muscle), FEELING ABNORMAL (feeling nasty), NAUSEA (nauseated the last couple of days), VOMITING (throwing up; vomiting started today), TREMOR (shaking real bad), HEART RATE INCREASED (heart rate went up) and BLOOD PRESSURE INCREASED (blood pressure went up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Aspirin she took the night before last (18Apr)
Respiratory infection, with fever. Treated with Prednisone, Clarithromycin 500mg BID, CLARITIN D and PROAIR inhaler 5 days after receiving vaccine.
Very brief period of nausea; Slight drowsiness lingering; Soreness in arm on side that received injection; Soreness in shoulder; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 28Mar2021 at 12:00 (at the age of 27-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included men daily multivitamin (MANUFACTURER UNKNOWN) and daily fiber supplement (MANUFACTURER UNKNOWN); both taken for unknown indication from unknown date. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021 at 12:15, the patient experienced very brief period of nausea, some slight drowsiness lingering to about 2-3 hours after injection and soreness in shoulder/arm on side that received injection which lasted till approximately 21 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events nausea, drowsiness pain in arm and shoulder pain was resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Developed Covid 9/25/2021: Headache, nasal congestion, sore throat, cough, loss of taste and smell Recovered from cough and congestion approx 30 days Loss of smell and taste - 6 weeks out and till lost
About 8 or 10 days after receiving the first Pfizer vaccine I developed a rash on my chest and abdomen.  It lasted for a couple weeks.  After receiving the second Pfizer vaccine the rash went away after a couple days.  Then, on approximately June 19th (75 days after the second vaccine dose) I noticed another rash on my back.  This time it spread all across my back, neck, chest, abdomen and arms.  It has been 6 days since the second rash began and it is still quite itchy and uncomfortable, although the rash severity does seem to be subsiding a bit.
The dose recommended by Moderna is 0.5ml. On 2/15/ 2021 a pharmacist administered the vaccine in my left arm . This person had previously been giving the Pfizer vaccine which is a 0.3 ml dose. By error she administered the Moderna dose at 0.3 ml which is 60% of the recommended dose.  I am concerned that this is an insufficient dose to protect against Covid 19. A second dose is scheduled for 3/15/21.
Our office had extra doses of the Covid vaccine toward the end of the day and offered them to people outside of our practice.  This child's parent stated that the child was 5 and provided a false birthdate.  The fake birthdate was not caught until after the vaccine had been administered and we were trying to enter the shot into the system.  At that point, we discovered that the child's birthday was not date, but other date.